These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38651512)

  • 1. An update on topical therapies for psoriasis.
    Pender EK; Kirby B
    Curr Opin Rheumatol; 2024 Jul; 36(4):289-294. PubMed ID: 38651512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Topical Therapies for Psoriasis.
    Lé AM; Torres T
    Am J Clin Dermatol; 2022 Jan; 23(1):13-24. PubMed ID: 34705167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Snape SD; Wigger-Alberti W; Goehring UM
    Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis.
    Smith B; Collier MR; Wu JJ
    JAMA; 2023 Feb; 329(7):594-595. PubMed ID: 36809326
    [No Abstract]   [Full Text] [Related]  

  • 5. Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis-Reply.
    Lebwohl MG; Hebert AA; Gooderham MJ
    JAMA; 2023 Feb; 329(7):595. PubMed ID: 36809324
    [No Abstract]   [Full Text] [Related]  

  • 6. Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol.
    Calverley PM; Martinez FJ; Fabbri LM; Goehring UM; Rabe KF
    Int J Chron Obstruct Pulmon Dis; 2012; 7():375-82. PubMed ID: 22791991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roflumilast for severe COPD?
    Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast (Daliresp) for COPD.
    Med Lett Drugs Ther; 2011 Jul; 53(1369):59-60. PubMed ID: 21778965
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
    Lebwohl MG; Kircik LH; Moore AY; Stein Gold L; Draelos ZD; Gooderham MJ; Papp KA; Bagel J; Bhatia N; Del Rosso JQ; Ferris LK; Green LJ; Hebert AA; Jones T; Kempers SE; Pariser DM; Yamauchi PS; Zirwas M; Albrecht L; Devani AR; Lomaga M; Feng A; Snyder S; Burnett P; Higham RC; Berk DR
    JAMA; 2022 Sep; 328(11):1073-1084. PubMed ID: 36125472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO).
    Gyldenløve M; Sørensen JA; Fage S; Meteran H; Skov L; Zachariae C; Knop FK; Nielsen ML; Egeberg A
    J Am Acad Dermatol; 2024 Jul; 91(1):64-71. PubMed ID: 38431099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
    Lebwohl MG; Papp KA; Stein Gold L; Gooderham MJ; Kircik LH; Draelos ZD; Kempers SE; Zirwas M; Smith K; Osborne DW; Trotman ML; Navale L; Merritt C; Berk DR; Welgus H;
    N Engl J Med; 2020 Jul; 383(3):229-239. PubMed ID: 32668113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe multi-refractory Sneddon-Wilkinson disease, with fast response to oral roflumilast treatment.
    Peñuelas Leal R; Grau Echevarría A; Labrandero Hoyos C; Blaya Imbernon D; Lorca Sprohnle J; Finello M; Mayo Martinez F; Zaragoza Ninet V
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e467-e469. PubMed ID: 38059421
    [No Abstract]   [Full Text] [Related]  

  • 13. Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.
    Papp KA; Gooderham M; Droege M; Merritt C; Osborne DW; Berk DR; Thurston AW; Smith VH; Welgus H
    J Drugs Dermatol; 2020 Aug; 19(8):734-740. PubMed ID: 32845114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults.
    Kalabalik-Hoganson J; Nogid A; Frey K
    J Drugs Dermatol; 2023 Aug; 22(8):761-765. PubMed ID: 37556516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis.
    Pixley JN; Schaetzle T; Feldman SR
    Ann Pharmacother; 2023 Aug; 57(8):966-969. PubMed ID: 36420929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roflumilast for asthma: Weighing the evidence.
    Bateman ED; O'Byrne PM; Buhl R; Rabe KF
    Pulm Pharmacol Ther; 2015 Dec; 35 Suppl():S1-3. PubMed ID: 26278190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical profile of roflumilast].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical therapies for psoriasis: evidence-based review.
    Afifi T; de Gannes G; Huang C; Zhou Y
    Can Fam Physician; 2005 Apr; 51(4):519-25. PubMed ID: 15856971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging topical treatments for psoriasis.
    Kivelevitch DN; Hebeler KR; Patel M; Menter A
    Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 2: Tapinarof.
    DiRuggiero M; Mancuso-Stewart E; DiRuggiero D; Zirwas M
    Skinmed; 2023; 21(3):177-181. PubMed ID: 37634099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.